Regulatory trends 2025

Get expert clarity on the latest ICH E6(R3) draft guidance and its impact on clinical trials.

In the kickoff session of our new LinkedIn Live series, Viedoc experts break down what the E6(R3) updates really mean — and how you can prepare. Whether you're a sponsor, CRO, or tech provider, this conversation is packed with practical insights to help you align with the new guidance.

What You’ll Learn:

•   Key changes introduced in the E6(R3) draft
•   How these updates affect trial planning, oversight, and tech implementation
•   Roles and responsibilities across sponsors, CROs, and vendors
•   What quality and compliance look like under the new framework

Why Watch:

•   Real-world perspectives from industry veterans and QA leaders
•   Focused guidance to help you adapt early and stay compliant
•   Includes a live Q&A with viewer-submitted questions